Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
British Journal of Haematology
|
May 31, 2001
Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia
O Bairey, Y Zimra, M Shaklai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas
O Bairey, Y Zimra, M Shaklai, et al.
Leukemia Research
|
February 3, 2007
Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line
E Rabizadeh, V Merkin, I Belyaeva, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells
Y Zimra, L Wasserman, L Maron, et al.
International Journal of Laboratory Hematology
|
April 8, 2014
Acute leukemia detection rate by automated blood count parameters and peripheral smear review
E Rabizadeh, I Pickholtz, M Barak, et al.
Leukemia Research
|
December 23, 2003
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
O Bairey, O Boycov, E Kaganovsky, et al.
Medical Oncology (Northwood, London, England)
|
December 15, 2000
Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas
O Bairey, Y Zimra, E Kaganovsky, et al.
European Journal of Haematology
|
May 31, 2001
Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient
E Rabizadeh, O Bairey, A Aviram, et al.
Journal of Cancer Research and Clinical Oncology
|
January 12, 2001
Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis
Y Zimra, A Nudelman, R Zhuk, et al.
European Journal of Haematology
|
September 21, 2000
Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease
A Aviram, E Rabizadeh, Y Zimra, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
British Journal of Haematology
|
May 31, 2001
Bcl-2 expression correlates positively with serum basic fibroblast growth factor (bFGF) and negatively with cellular vascular endothelial growth factor (VEGF) in patients with chronic lymphocytic leukaemia
O Bairey, Y Zimra, M Shaklai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas
O Bairey, Y Zimra, M Shaklai, et al.
Leukemia Research
|
February 3, 2007
Pivanex, a histone deacetylase inhibitor, induces changes in BCR-ABL expression and when combined with STI571, acts synergistically in a chronic myelocytic leukemia cell line
E Rabizadeh, V Merkin, I Belyaeva, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1997
Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells
Y Zimra, L Wasserman, L Maron, et al.
International Journal of Laboratory Hematology
|
April 8, 2014
Acute leukemia detection rate by automated blood count parameters and peripheral smear review
E Rabizadeh, I Pickholtz, M Barak, et al.
Leukemia Research
|
December 23, 2003
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
O Bairey, O Boycov, E Kaganovsky, et al.
Medical Oncology (Northwood, London, England)
|
December 15, 2000
Microvessel density in chemosensitive and chemoresistant diffuse large B-cell lymphomas
O Bairey, Y Zimra, E Kaganovsky, et al.
European Journal of Haematology
|
May 31, 2001
Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient
E Rabizadeh, O Bairey, A Aviram, et al.
Journal of Cancer Research and Clinical Oncology
|
January 12, 2001
Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis
Y Zimra, A Nudelman, R Zhuk, et al.
European Journal of Haematology
|
September 21, 2000
Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease
A Aviram, E Rabizadeh, Y Zimra, et al.
Page
of 2